Camelidae and Cervidae Bluetongue Virus Study Guide

Overview and Clinical Importance

Bluetongue virus (BTV) is an arthropod-borne, non-contagious viral disease caused by a member of the genus Orbivirus within the family Sedoreoviridae. BTV affects domestic and wild ruminants as well as camelids worldwide. While sheep are classically considered the most susceptible species with severe clinical disease, both camelids (llamas, alpacas, camels) and cervids (white-tailed deer, mule deer, elk, red deer) exhibit variable susceptibility ranging from subclinical infection to fatal hemorrhagic disease.

Understanding BTV in camelids and cervids is essential for NAVLE preparation because these species are increasingly common in veterinary practice, outbreaks can cause significant mortality in naive populations, and the disease has important regulatory and trade implications.

Etiology

Viral Classification: BTV belongs to the genus Orbivirus, family Sedoreoviridae (formerly Reoviridae). The virus is a non-enveloped, double-stranded RNA virus with a triple-layered icosahedral capsid structure.

Viral Structure

• Genome: 10 segments of linear dsRNA encoding 7 structural proteins (VP1-VP7) and 4 non-structural proteins (NS1-NS4)
• Outer Capsid: VP2 (serotype-specific, neutralizing antibody target) and VP5 (hemagglutinin)
• Core Surface: VP7 (group-specific antigen for serogroup diagnosis)
• Subcore: VP3 and enzymatic proteins VP1, VP4, VP6

BTV Serotypes

At least 29 serotypes of BTV have been identified worldwide. Serotype determination is based on VP2 protein variations.

Transmission and Epidemiology

Vector Transmission

BTV is primarily transmitted by biting midges of the genus Culicoides (Diptera: Ceratopogonidae). These small (1-3 mm) hematophagous flies are essential biological vectors for typical BTV serotypes.

Principal Culicoides Vector Species by Region

Other Transmission Routes

• Transplacental: BTV crosses placenta causing fetal abnormalities (hydranencephaly, porencephaly)
• Venereal: BTV shed in semen; important for breeding programs
• Direct contact: Documented for atypical serotypes (BTV-25 to BTV-27)
• Iatrogenic: Through contaminated needles or blood products

Seasonality and Geographic Distribution

BTV transmission is highly seasonal and dependent on vector activity. In temperate regions, disease occurs from late summer through autumn (August-November) when Culicoides populations peak. Transmission ceases after the first hard frost kills adult midges.

Geographic range: Historically limited to latitudes 35S to 40-50N, but climate change has expanded BTV distribution northward into Northern Europe.

Species Susceptibility

Camelidae (Llamas, Alpacas, Camels)

South American camelids were historically considered relatively resistant to BTV. However, recent reports have documented fatal infections, particularly with BTV-1 and BTV-8 serotypes.

Key Points for Camelids

• Generally show subclinical to mild disease; most infections are inapparent
• Seroconversion occurs 6-8 days post-infection (ELISA); neutralizing antibodies appear 10-13 days post-infection
• Viremia is typically low and short-lived; virus clears quickly after seroconversion
• Lower BTV adsorption to camelid erythrocytes may explain reduced susceptibility
• Fatal cases reported with BTV-1 (France), BTV-8 (Europe), BTV-11 (USA) - severe pulmonary edema

Cervidae (Deer, Elk, and Related Species)

White-tailed deer (Odocoileus virginianus) are among the most susceptible species to both BTV and EHDV with high mortality in naive populations.

Cervid Species Susceptibility Comparison

Clinical Signs and Presentation

Clinical presentation of BTV is summarized by the mnemonic "FFF" (Fever, Face, Feet). Incubation period is typically 5-20 days.

Clinical Signs in Camelids

Most camelid infections are subclinical or produce mild, nonspecific signs. When clinical disease occurs, it may include:

• Fever (often transient and mild)
• Anorexia and lethargy
• Respiratory signs: Polypnea, dyspnea, hiccup-like breathing, nasal discharge
• Oral lesions: Erosions/ulcers on tongue, palate, buccal mucosa (fatal cases)
• Facial and dependent edema
• Reproductive losses: Abortion documented with BTV-1

Fatal BTV Infection in Camelids

Fatal cases characterized by acute respiratory distress with severe pulmonary edema. Abundant foam from mouth and nostrils before death. At necropsy, lungs heavy, edematous, fail to collapse.

Clinical Signs in Cervids

Disease in cervids presents in three forms: peracute, acute, and chronic.

Key Clinical Signs in Cervids

• Fever with animals seeking bodies of water to cool
• Loss of fear of humans, weakness, lethargy
• Swelling of head, neck, tongue, eyelids
• Excessive salivation (often blood-tinged)
• Nasal discharge (serous to blood-tinged)
• Cyanosis of oral mucosa ("blue tongue" - inconsistent finding)
• Bloody diarrhea (hemorrhagic gastroenteritis)
• Torticollis (neck torsion) in severe cases

Pathology

Pathogenesis

After Culicoides bite, BTV is transported by dendritic cells to regional lymph nodes (primary replication), then disseminates via blood to secondary organs, replicating in vascular endothelium and mononuclear phagocytes.

Endothelial damage leads to: Increased vascular permeability (edema/effusions); cytokine release ("cytokine storm"); hemorrhage; thrombosis and DIC; tissue necrosis.

Gross Pathological Findings

External Lesions

• Facial and dependent edema (submandibular, cervical)
• Hyperemia and edema of lips, tongue, muzzle
• Oral erosions and ulcers (dental pad, buccal mucosa, tongue)
• Coronitis (hyperemia of coronary band)
• Hoof sloughing/growth interruption lines (chronic cases)

Internal Lesions

• Pulmonary edema (lungs heavy, wet, fail to collapse; frothy airways)
• Hemorrhage at BASE of PULMONARY ARTERY - PATHOGNOMONIC
• Focal necrosis of LEFT VENTRICULAR PAPILLARY MUSCLE - HIGHLY CHARACTERISTIC
• Hydrothorax and hydropericardium
• Hemorrhages in skeletal muscles, myocardium, rumen, intestines

Fetal and Congenital Lesions

• Hydranencephaly (cerebral hemispheres replaced by fluid)
• Porencephaly ("Swiss cheese" brain)
• Cerebellar hypoplasia
• Dummy calf/lamb syndrome

Diagnosis

Diagnosis requires laboratory confirmation. A combination of agent identification and serology is recommended.

Diagnostic Testing Methods

Sample Collection Guidelines

• Live animals: Whole blood in EDTA during febrile, viremic stage
• Dead animals: Spleen, lymph nodes, lung; refrigerate (do NOT freeze)
• Serology: Serum; antibodies develop 7-14 days post-infection, persist lifelong

Differential Diagnosis

BTV versus EHD in Cervids

BTV and EHD produce clinically indistinguishable hemorrhagic disease in deer. Laboratory testing (RT-PCR) is required to distinguish them. The term "hemorrhagic disease" (HD) is used collectively when the specific virus is unknown.

Key difference: EHD primarily affects white-tailed deer and rarely causes clinical disease in livestock. BTV can cause severe disease in sheep and occasionally cattle.

Treatment and Management

There is no specific antiviral treatment for BTV. Management is entirely supportive and symptomatic.

Supportive Care Measures

Prevention and Control

Vector Control

Since BTV is vector-borne and non-contagious, reducing Culicoides exposure is key:

• House animals indoors during peak midge activity (dawn/dusk)
• Fine mesh screens on barns (midges are 1-3 mm)
• Insecticide application (pyrethroids on animals and premises)
• Eliminate standing water/muddy areas where midges breed
• Fans in housing to disrupt midge flight (weak fliers)

Vaccination

Vaccination is most effective for BTV control in livestock. However, vaccines are serotype-specific, providing limited cross-protection.

Camelids and cervids: No BTV vaccines specifically licensed for camelids or wildlife. Off-label use may be considered. No EHD vaccines exist for the US.

Regulatory Considerations

• Notifiable disease: BTV is a WOAH-listed disease requiring notification
• Movement restrictions: Outbreaks trigger restricted zones and trade restrictions
• Report immediately to state and federal animal health authorities

Prognosis

Recovery: Survivors develop long-lasting immunity to the infecting serotype. Convalescence may be prolonged. Chronic survivors may have permanent hoof damage.